Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Are FDA Delays Good or Bad for Investors?

Let's face it, investors -- FDA decisions can be confusing.

Delays in particular can be difficult to decipher. They can sometimes signal serious problems that investors need to be wary of, and other times they just mean that the agency needs more time to analyze data. In the following video, our health care analyst Max Macaluso looks at how FDA delays can affect investors, and he draws from recent examples at fledgling orphan drugmaker Raptor Pharmaceutical (NASDAQ: RPTP  ) , Eliquis developers Pfizer (NYSE: PFE  ) and Bristol-Myers Squibb (NYSE: BMY  ) , obesity drugmaker VIVUS  (NASDAQ: VVUS  ) , and inhalable insulin developer MannKind (NASDAQ: MNKD  ) .

The health care space may offer investors many opportunities, but this is also one of the market's riskiest sectors. Motley Fool co-founder David Gardner's picks, which range across many sectors, have frequently trounced the market.

How? Because he's always on the lookout for revolutionary stocks and recommends them before Wall Street catches on to their disruptive potential. If you're interested in how David discovers his winners, click here to get instant access to a personal tour behind David's Supernova service.

Read/Post Comments (2) | Recommend This Article (5)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 07, 2013, at 6:39 AM, RSRdriver wrote:

    You know what a better question here at Motley would be?

    Does credibility matter in Motley Fool "articles" matter anymore?

    This article is pertinent. However, in a matter of minutes or hours at the most we will be inundated with the usual weekly pumps from the Areniac "writers" who are really nothing more than shills.

    Allowing this abuse of your platform is not giving you any points in the honesty in journalism department.

    I and others would like to know when it will stop?

  • Report this Comment On January 13, 2013, at 1:48 PM, TelsaRowe wrote:
Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2179833, ~/Articles/ArticleHandler.aspx, 9/30/2016 9:41:48 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 25 minutes ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 4:05 PM
BMY $53.92 Up +0.05 +0.09%
Bristol-Myers Squi… CAPS Rating: ****
MNKD $0.62 Up +0.02 +3.63%
MannKind CAPS Rating: *
PFE $33.87 Up +0.55 +1.65%
Pfizer CAPS Rating: ****
RPTP $8.97 Down +0.00 +0.00%
Raptor Pharmaceuti… CAPS Rating: **
VVUS $1.14 Up +0.01 +0.88%
VIVUS CAPS Rating: **